Screening for Endometrial Abnormalities in Overweight and Obese Women
Not Applicable
Completed
- Conditions
- Endometrial Cancer
- Registration Number
- NCT01922778
- Lead Sponsor
- St. Luke's-Roosevelt Hospital Center
- Brief Summary
The purpose of this study is to develop an endometrial biopsy screening program for endometrial cancer and its precursor lesions in overweight and obese women.
There is a BMI threshold at and above which optimal screening parameters exist for identifying endometrial cancer and its precursor lesions in overweight and/or obese women. Prevention, diagnosis and treatment of endometrial cancer and its precursor lesions in overweight and/or obese women offers substantial health benefits.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Female
- Target Recruitment
- 303
Inclusion Criteria
Not provided
Exclusion Criteria
Not provided
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Primary Outcome Measures
Name Time Method A BMI cut-point will be identified at and above which an endometrial biopsy yields optimal sensitivity, specificity, positive predictive value, and negative predictive value to screen for endometrial cancer and abnormal pathologies up to 1 year
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Mount Sinai Roosevelt
🇺🇸New York, New York, United States
Mount Sinai Roosevelt🇺🇸New York, New York, United States